Portable Motion Compensated SDOCT System for Imaging Young Children

用于幼儿成像的便携式运动补偿 SDOCT 系统

基本信息

  • 批准号:
    8243852
  • 负责人:
  • 金额:
    $ 22.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-01-01 至 2013-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Eye diseases of young children, if not detected and treated early, can lead to serious vision loss and even blindness. Currently, retinal diseases in young children are mainly recorded and monitored by color photographs, even though they provide limited information about ophthalmic disease processes and mechanisms. As an alternative to the classic 2-D color photographs, novel spectral domain optical coherence tomography (SDOCT) imaging systems can provide 3-D images of intra-retinal structures. In adults, tabletop SDOCT provides significantly more useful diagnostic information and is now a standard for the diagnosis and management of retinal diseases. Our preliminary studies based on handheld SDOCT (HH-SDOCT) snapshots of neonatal retina have already provided some unique and previously unseen information about disease progression in young children. However, due to the infant's head/eye motion, it is extremely cumbersome to effectively image a complete 3-D tomographic view of the macula in young, awake children and accurately measure and quantify disease biomarkers. Our long-term goal is to improve the vision outcomes of at-risk young children with ocular diseases through earlier and better-directed therapy. To achieve this goal, we will take advantage of recent advances in image processing and optics as an integrated technology to capture 3-D retinal images with higher resolution and better motion stability compared to any previous imaging technique, which will ultimately provide quantitative measurements of novel imaging biomarkers of the onset and progression of young children's ophthalmic diseases. We will achieve our objectives by pursuit of the following three specific aims: Aim 1: Develop hardware to customize the handheld SDOCT and Doppler-SDOCT systems for retinal imaging of non- sedated young children. Aim 2: Develop software to control the hardware in Aim 1 and to automatically analyze the captured images for detecting imaging biomarkers of the onset and progression of retinal diseases in young children. Aim 3: Perform a pilot study in adults and young children. Evaluate, provide feedback, and improve the performance of methodologies in Aims 1&2, and then test the utility and validity of images and measurements compared to conventional diagnostic methods. The results of this study have the potential to provide practical diagnostic tools and methodologies that will revolutionize the management of pediatric ocular diseases. This contribution would be significant as the first step in a continuum of research leading to better-directed therapy of ocular diseases in young children based on accurate quantitative measurement of disease imaging biomarkers and accurate staging of foveal development. PUBLIC HEALTH RELEVANCE: Eye diseases of young children, if not detected and treated early, can lead to serious vision loss and even blindness. We propose to develop a technology to adapt spectral domain optical coherence tomography imaging systems, currently widely used for imaging adults, as a novel and efficient ocular disease diagnostic tool in young, awake children.
描述(申请人提供):幼儿的眼部疾病如果不及早发现和治疗,会导致严重的视力丧失甚至失明。目前,幼儿视网膜疾病主要通过彩色照片进行记录和监测,尽管它们提供的有关眼科疾病过程和机制的信息有限。作为经典 2D 彩色照片的替代方案,新型谱域光学相干断层扫描 (SDOCT) 成像系统可以提供视网膜内结构的 3D 图像。对于成人,桌面 SDOCT 提供了更有用的诊断信息,现已成为视网膜疾病诊断和治疗的标准。我们基于新生儿视网膜手持式 SDOCT (HH-SDOCT) 快照的初步研究已经提供了一些有关幼儿疾病进展的独特且以前未见过的信息。然而,由于婴儿的头部/眼睛运动,有效地对年幼、清醒的儿童的黄斑进行完整的 3D 断层扫描视图成像并准确测量和量化疾病生物标志物是极其麻烦的。我们的长期目标是通过更早、更有针对性的治疗来改善患有眼部疾病的高危幼儿的视力结果。为了实现这一目标,我们将利用图像处理和光学方面的最新进展作为一种集成技术来捕获 3D 视网膜图像,与任何以前的成像技术相比,其分辨率更高,运动稳定性更好,这最终将提供新颖的定量测量。幼儿眼科疾病发病和进展的成像生物标志物。我们将通过追求以下三个具体目标来实现我们的目标: 目标 1:开发硬件来定制手持式 SDOCT 和多普勒-SDOCT 系统,用于非镇静幼儿的视网膜成像。目标 2:开发软件来控制目标 1 中的硬件并自动分析捕获的图像,以检测幼儿视网膜疾病发病和进展的成像生物标志物。目标 3:在成人和幼儿中进行试点研究。评估、提供反馈并改进目标 1 和 2 中的方法的性能,然后与传统诊断方法相比测试图像和测量的实用性和有效性。这项研究的结果有可能提供实用的诊断工具和方法,从而彻底改变儿科眼部疾病的管理。这一贡献将是意义重大的,作为连续研究的第一步,基于疾病成像生物标志物的准确定量测量和中心凹发育的准确分期,可以更好地指导幼儿眼部疾病的治疗。 公共卫生相关性:幼儿的眼部疾病如果不及早发现和治疗,可能会导致严重的视力丧失甚至失明。我们建议开发一种技术来适应目前广泛用于成人成像的谱域光学相干断层扫描成像系统,作为年幼清醒儿童的一种新颖有效的眼部疾病诊断工具。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sina Farsiu其他文献

Sina Farsiu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sina Farsiu', 18)}}的其他基金

NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial with retinitis pigmentosa: OCT Reading Center
NAC Attack,一项针对色素性视网膜炎的 3 期、多中心、随机、安慰剂对照试验:OCT 阅读中心
  • 批准号:
    10593932
  • 财政年份:
    2022
  • 资助金额:
    $ 22.18万
  • 项目类别:
Blink, Lacrimation, and Nociception: Precision Mapping and Integrated Atlas Generation of Corneal Trigeminal Afferents
眨眼、流泪和伤害感受:角膜三叉神经传入的精确绘图和集成图谱生成
  • 批准号:
    10585769
  • 财政年份:
    2022
  • 资助金额:
    $ 22.18万
  • 项目类别:
Blink, Lacrimation, and Nociception: Precision Mapping and Integrated Atlas Generation of Corneal Trigeminal Afferents
眨眼、流泪和伤害感受:角膜三叉神经传入的精确绘图和集成图谱生成
  • 批准号:
    10707309
  • 财政年份:
    2022
  • 资助金额:
    $ 22.18万
  • 项目类别:
NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial with retinitis pigmentosa: OCT Reading Center
NAC Attack,一项针对色素性视网膜炎的 3 期、多中心、随机、安慰剂对照试验:OCT 阅读中心
  • 批准号:
    10593932
  • 财政年份:
    2022
  • 资助金额:
    $ 22.18万
  • 项目类别:
NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial with retinitis pigmentosa: OCT Reading Center
NAC Attack,一项针对色素性视网膜炎的 3 期、多中心、随机、安慰剂对照试验:OCT 阅读中心
  • 批准号:
    10333125
  • 财政年份:
    2022
  • 资助金额:
    $ 22.18万
  • 项目类别:
Quantitative assessment of glaucomatous conventional outflow dynamics
青光眼常规流出动力学的定量评估
  • 批准号:
    9913541
  • 财政年份:
    2019
  • 资助金额:
    $ 22.18万
  • 项目类别:
Quantitative assessment of glaucomatous conventional outflow dynamics
青光眼常规流出动力学的定量评估
  • 批准号:
    10397034
  • 财政年份:
    2019
  • 资助金额:
    $ 22.18万
  • 项目类别:
Handheld Portable Adaptive Optics Scanning Laser Ophthalmoscope for Imaging Young Children
用于幼儿成像的手持式便携式自适应光学扫描激光检眼镜
  • 批准号:
    9167486
  • 财政年份:
    2016
  • 资助金额:
    $ 22.18万
  • 项目类别:
Computer Aided Classification of Diabetic Macular Edema
糖尿病黄斑水肿的计算机辅助分类
  • 批准号:
    8703708
  • 财政年份:
    2012
  • 资助金额:
    $ 22.18万
  • 项目类别:
Computer Aided Classification of Diabetic Macular Edema
糖尿病黄斑水肿的计算机辅助分类
  • 批准号:
    8348365
  • 财政年份:
    2012
  • 资助金额:
    $ 22.18万
  • 项目类别:

相似国自然基金

基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
  • 批准号:
    82372499
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
  • 批准号:
    82373465
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
  • 批准号:
    82300208
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Using hiPSCs to develop physiologically-relevant outer retina tissue mimetics
使用 hiPSC 开发生理相关的外视网膜组织模拟物
  • 批准号:
    10467753
  • 财政年份:
    2022
  • 资助金额:
    $ 22.18万
  • 项目类别:
Development and Validation of Photothermal Optical Coherence Tomography for Retinal Imaging
用于视网膜成像的光热光学相干断层扫描的开发和验证
  • 批准号:
    10380391
  • 财政年份:
    2022
  • 资助金额:
    $ 22.18万
  • 项目类别:
Using hiPSCs to develop physiologically-relevant outer retina tissue mimetics
使用 hiPSC 开发生理相关的外视网膜组织模拟物
  • 批准号:
    10709483
  • 财政年份:
    2022
  • 资助金额:
    $ 22.18万
  • 项目类别:
Development and Validation of Photothermal Optical Coherence Tomography for Retinal Imaging
用于视网膜成像的光热光学相干断层扫描的开发和验证
  • 批准号:
    10550200
  • 财政年份:
    2022
  • 资助金额:
    $ 22.18万
  • 项目类别:
Development of the First-ever Safe and Effective Anterior Chamber Paracentesis Instrument to Treat and Diagnose Ocular Diseases
开发首个安全有效的前房穿刺器械来治疗和诊断眼部疾病
  • 批准号:
    10325880
  • 财政年份:
    2021
  • 资助金额:
    $ 22.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了